期刊文献+

hVEGF_(165)四环素调控腺病毒载体的构建及其在大鼠成肌细胞表达

Construction of tetracycline-regulative adenoviral vector containing human vascular endothelial growth factor 165 gene and its expression in rat myoblast
下载PDF
导出
摘要 目的构建表达人血管内皮生长因子165基因(hVEGF165)的四环素调控重组腺病毒,并测定其在原代培养大鼠成肌细胞的表达水平。方法亚克隆hVEGF165全长cDNA到穿梭质粒pTREShuttle2,获得四环素可调控的目的基因表达盒;亚克隆表达盒到BDAdeno-XTMViralDNA,获得重组腺病毒质粒;重组质粒转染HEK293细胞以包装产生具有感染能力的重组腺病毒颗粒AdTRE.VEGF165。hVEGF165重组腺病毒和Tetoff调节病毒共感染原代培养的成肌细胞,酶联免疫法检测目的基因的表达。结果成功构建了能表达hVEGF165的四环素调控的重组腺病毒载体。hVEGF165重组腺病毒(20pfu/cell)和Tetoff调控病毒(20pfu/cell)共感染骨骼肌成肌细胞后5d,ELISA检测显示培养上清中VEGF165蛋白浓度显著高于未感染的细胞培养上清[(14.80±1.15ng/ml)×105/(cell·24h)vs(1.39±0.36ng/ml)×105/(cell·24h),P<0.01)]。结论四环素调控表达的腺病毒系统可高效地转导VEGF基因进入哺乳动物细胞;原代培养的骨骼肌成肌细胞感染AdTRE.VEGF165后可高水平地分泌VEGF165蛋白。 AIM To construct tetracycline (Tet)-regulatable recombinant adenovirus containing human vascular endothelial growth factor 165 gene (hVEGF165 ), and to detect its expression in myoblast. METHODS A Tet-responsive mammalian expression cassette, which could be regulated by tetracycline, was made by subcloning the full-length cDNA encoding hVEGF165into pTRE-Shuttle2 vector. The expression cassette was then subcloned into the BD Adeno-XTM Viral DNA to form an adenoviral plasmid. Next, the recombinant plasmid was packaged into infectious recombinant adenoviral particles by transfecting HEK 293 cells. Primary rat skeletal myoblasts were infected with both the hVEGF165 recombinant adenovirus and Tet-off regulatory virus. Expression was tested by enzyme-linked immunosorbent assay. RESULTS We successfully constructed a tetracycline regulatable recombinant adenoviruses vector containing the cDNA for human VEGF165, a secreted endothelial cell specific angiogenic growth factor. The primary skeletal myoblasts infected with AdTRE. VEGF165 (20 pfu/cell) and Tet-off regulatory virus ( 20 pfu/cell) demonstrated higher VEGF165 protein secretion into the supernatant compared with uninfected group[ (14.80±1.15 ng/ml)×10^5/(cell·24 h) vs ( 1.39 ± 0. 36 ng/ml) × 10^5/(cell· 24h), P 〈0.01 ] , as measured by ELISA at 5 d after infection. CONCLUSION Tet-regulatable adenoviral expression systems are used to deliver gene of VEGF into mammalian cells efficiently. The primary skeletal myoblasts infected with AdTRE. VEGF165 secretes VEGF165 protein at high levels.
出处 《心脏杂志》 CAS 2006年第1期35-38,42,共5页 Chinese Heart Journal
基金 国家自然科学基金项目资助(No.30070750)
关键词 血管内皮生长因子 成肌细胞 重组腺病毒 基因治疗 VEGF myoblast recombinant adenoviruses gene therapy
  • 相关文献

参考文献9

  • 1Yla-Herttuala S,Alitalo K.Gene transfer as a tool to induce therapeutic vascular growth[J].Nat Med,2003,9:694-701.
  • 2Lee RJ,Springer ML,Blanco-Bose WE,et al.VEGF gene delivery to myocardiun:deleterious effects of unregulated expression[J].Circulation,2000,102:898-901.
  • 3周菲,秦永文,荆清,沈茜,马大烈.成年大鼠成肌细胞的原代培养[J].中华老年心脑血管病杂志,2001,3(1):43-46. 被引量:7
  • 4Ozawa CR,Banfi A,Glazer NL,et al.Microenvironmental VEGF concentration,not total dose,determines a threshold between normal and aberrant angiogenesis[J].J Clin Invest,2004,113(4):516 -527.
  • 5Suzuki K,Murtuza B,Smolenski RT,et al.Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts[J].Circulation,2001,104(Suppl Ⅰ):I207-I212.
  • 6Menasche P.Myoblast-based cell transplantation[J].Heart Fail Rev,2003,8 (3):221-227.
  • 7von Degenfeld G,Banff A,Springer ML,et al.Myoblast-mediated gene transfer for therapeutic angiogenesis and arteriogenesis[J].Br J Pharmacol,2003,140(4):620 -626.
  • 8Germani A,Di Carlo A,Mangoni A,et al.Vascular endothelial growth factor modulates skeletal myoblast function[J].Am J Pathol,2003,163(4):1417-1428.
  • 9郝亚荣,李庚山,李建军,王晶,赵智深,赵志明.血管内皮生长因子对培养内皮细胞合成一氧化氮的影响[J].心脏杂志,2002,14(3):186-188. 被引量:4

二级参考文献22

  • 1[1]Lero J, Prentice H, Sartorelli V et al. Gene transfer and cell transplant: an experimental approach to repair a ‘ broken heart' [ J ]. Cardiovasc Res,1997,35:431 - 441.
  • 2[2]Atkins BZ, Lewis CW, Kraus WE et al. Intracardiac transplantation of skeletal myoblasts yields two populations of striated cells[ J]. Ann Thorac Surg, 1999,67:124 - 129.
  • 3[3]Taylor DA, Atkins BZ, Hungspreugs P et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation[ J].Nat Med , 1998,4:929 - 933.
  • 4[4]Rando TA, Blau HM. Primary mouse myoblast purification, characterization,and transplantation for cell-mediated gene therapy[J]. J Cell Biol,1994,125:1275 - 1287.
  • 5[5]Mayer NJ, Rubin SA. Molecular and cellular prospects for repair, augmentation,and replacement of the failing heart[J]. Am Heart J, 1997, 134:577 - 586.
  • 6[6]Blau HM, Jyotsna D. Myoblasts in pattern formation and gene therapy[J].Science, 1993,9: 269 - 274.
  • 7[7]Li RK, Mickle DA, Weisel RD et al. Natural history of fetal rat cardiomyocytes transplanted into adult rat myocardial scar tissue[J]. Circulation, 1997,96(suppl Ⅱ ):179- 186.
  • 8[8]Blau HM, Webster C. Isolation and characterization of human muscle cells [J] .Proc Natl Acad Sci USA, 1981,78:5623- 5627.
  • 9[1]Kuwabara K,Ogawa S,Matsumoto M,et al.Hypoxia-mediated induction of acid/basic fibroblast growth factor and platelet derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells[J].Proc Natl Acad Sci USA,1995,92:4606-6910.
  • 10[2]De Vries C,Escobedo JA,Ueno H,et al.The fms-like tyrosine kinase,a receptor for vascular endothelial growth factor[J].Science,1992,255:989-991.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部